Neogen Corporation · NASDAQ:NEOG

Neogen — 41st Annual J.P. Morgan Healthcare Conference 2023

14 slides from Neogen's conference presentation, Jan 11, 2023

  1. Slide 1: JP Morgan Healthcare Conference

    JP Morgan Healthcare Conference January 11, 2023 ©2020 NEOGEN Corporation. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements This presentation includes “forward-looking statements” as that term is defined in Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified b

  3. Slide 3: Neogen's Mission and Vision for the Future

    Neogen’s Mission and Vision for the Future The mission of Our VISION for the FUTURE Neogen Corporation We will continue to play a key role in enhancing is to be the leading company the safety, quality and quantity in the development and marketing of the global food supply of solutions for food and a

  4. Slide 4: Neogen and 3M Food Safety – A Compelling Combination

    Neogen and 3M Food Safety – A Compelling Combination Creating a Global Leader in Food Security Neogen 3M Food Safety Combined Company Broader A leading pure-play food security product offerings to enhance company, spanning food safety, A leader in food safety solutions customer solutions animal safe

  5. Slide 5: Former 3M Food Safety Division – Product Offerings

    Former 3M Food Safety Division – Product Offerings Indicator Hygiene Sample Pathogen Allergen Testing Monitoring Handling Detection Testing Revenue ~55% ~14% ~14% ~14% < 3% Recurring revenue Contribution driven by >95% of revenues attributed to consumable products Consumables Hygiene monitoring and

  6. Slide 6: Legacy Neogen – Product Offerings

    Legacy Neogen – Product Offerings Food Safety Animal Safety Genomics Protecting the Food Supply Ensuring Wellbeing of Livestock & Pets Improving Food Security  Food safety products that reach all segments  Develop solutions for animal protein, animal  Develop solutions that allow protein producer

  7. Slide 7: Well-Positioned to Address Global Food Security Challenges

    Well-Positioned to Address Global Food Security Challenges Serving Large and …with Attractive …Addressed by a Comprehensive Growing Markets… Long-Term Fundamentals… Offering of Global Solutions Est. Market Est. LT Significant Tailwinds Product Mix Size Growth Rate  Increasing health conscious consu

  8. Slide 8: Integrated Offering Covering the Global Food Security Chain

    Integrated Offering Covering the Global Food Security Chain Regulatory Focus Genomic Improvement Feed Production Biosecurity & Hygiene Food Security Agriculture and Diagnostic Farm Production Screening Consumer Processing Testing and Compliance 8 ©2023 Neogen Corporation. All rights reserved.

  9. Slide 9: Integration Fully Underway

    Integration Fully Underway Pre-Closing Since Closing Deep understanding of market dynamics and High quality of acquired business has been competitive landscape confirmed Commercial organizations combined, synergy Broad product expertise targets prioritized In-touch with customer demands Collaborativ

  10. Slide 10: Fundamentally Enhanced Financial Profile

    Fundamentally Enhanced Financial Profile Fiscal Year Ending May 31, 2022 (Pre-Merger) 2025 (Target) Revenue $527 million ~$1 billion Adjusted EBITDA $115 million ~$300 million Adjusted EBITDA Margin 22% ~30% World-class food security company well-positioned to capitalize on resilient end markets and

  11. Slide 11: Well-Positioned to Extend Strong Track Record of Growth

    Well-Positioned to Extend Strong Track Record of Growth Neogen and 3M Food Safety Revenue Growth (FY2000 – FY2022) 23-Year CAGR: ~9% (largely organic) 23-Year CAGR: ~15% (organic + M&A) 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

  12. Slide 12: Appendix

    Appendix ©2023 Neogen Corporation. All rights reserved.

  13. Slide 13: Key Takeaways

    Key Takeaways Combination of complementary food safety leaders creating a pure- play food security company with ~$1 billion revenue trajectory Broad portfolio of critical products for growing, resilient end market with favorable long-term secular trends Original acquisition thesis remains firmly int

  14. Slide 14: Non-GAAP Reconciliations

    Non-GAAP Reconciliations 14 ©2023 Neogen Corporation. All rights reserved.

Neogen — 41st Annual J.P. Morgan Healthcare Conference 2023 on 6ix